Bill Sponsor
Senate Bill 3588
117th Congress(2021-2022)
Medical Countermeasures Surge Capacity Act of 2022
Introduced
Introduced
Introduced in Senate on Feb 7, 2022
Overview
Text
Introduced
Feb 7, 2022
Latest Action
Feb 7, 2022
Origin Chamber
Senate
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
3588
Congress
117
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Sponsorship by Party
Republican
Utah
Democrat
New Hampshire
Senate Votes (0)
House Votes (0)
No Senate votes have been held for this bill.
Summary

Medical Countermeasures Surge Capacity Act of 2022

This bill expands the scope of research and development activities carried out by the Biomedical Advanced Research and Development Authority (BARDA) to include support for maintaining and improving domestic manufacturing surge capacity and capabilities for vaccines, diagnostics, and other medical countermeasures.

In particular, BARDA must enter into transactions with facilities to ensure that domestic manufacturing surge capacity is available to manufacture medical countermeasures and related products in the event of a public health emergency (e.g., by supporting flexible or advanced manufacturing). The Government Accountability Office must report on these efforts.

In addition, BARDA must address support for domestic manufacturing surge capacity in its strategic plan for countermeasure research, development, and procurement.

The bill also reauthorizes through FY2028 a program through which BARDA may support innovative technologies to assist in medical countermeasure research and development using grants, cooperative agreements, and other transactions.

Text (1)
February 7, 2022
Actions (2)
02/07/2022
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
02/07/2022
Introduced in Senate
Public Record
Record Updated
Dec 29, 2022 9:18:19 PM